Ercan, Caner http://orcid.org/0000-0002-5611-2699
Kordy, Kattayoun
Knuuttila, Anna
Zhou, Xiaofei
Kumar, Darshan
Koponen, Ville
Mesenbrink, Peter
Eppenberger-Castori, Serenella
Amini, Parisa
Pedrosa, Marcos C.
Terracciano, Luigi M.
Funding for this research was provided by:
Novartis Institutes for BioMedical Research
University of Basel
Article History
Received: 15 December 2023
Revised: 2 May 2024
Accepted: 30 May 2024
First Online: 15 June 2024
Declarations
:
: Caner Ercan, Serenella Eppenberger-Castori, and Luigi M. Terracciano have no conflicts to declare. Anna Knuuttila and Darshan Kumar are employees and shareholders of Aiforia Technologies. Ville Koponen is associated with Aiforia Technologies, however, does not have any conflict of interest to declare. Xiaofei Zhou and Peter Mesenbrink are employees and shareholders of Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. Kattayoun Kordy was an employee and shareholder of Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. Parisa Amini is an employee of Novartis Pharma AG, Basel, Switzerland. Marcos C. Pedrosa was an employee and shareholder of Novartis Pharma AG, Basel, Switzerland.